Symbol="TSHA"
AssetType="Common Stock"
Name="Taysha Gene TherapiesÂ Inc"
Description="Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company is headquartered in Dallas, Texas."
CIK="1806310"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="7318 MORTON STREET, DALLAS, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="631644000"
EBITDA="-77633000"
PERatio="None"
PEGRatio="None"
BookValue="-0.576"
DividendPerShare="0"
DividendYield="0"
EPS="-2.32"
RevenuePerShareTTM="0.171"
ProfitMargin="0"
OperatingMarginTTM="-8.22"
ReturnOnAssetsTTM="-0.441"
ReturnOnEquityTTM="-7.45"
RevenueTTM="9603000"
GrossProfitTTM="2502000"
DilutedEPSTTM="-2.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5.72"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="13.3"
EVToRevenue="-"
EVToEBITDA="-1.135"
Beta="1.165"
num_52WeekHigh="4.058"
num_52WeekLow="0.5"
num_50DayMovingAverage="1.045"
num_200DayMovingAverage="1.239"
SharesOutstanding="186877000"
DividendDate="None"
ExDividendDate="None"
symbol="TSHA"
open="3.49"
high="3.55"
low="3.11"
price="3.28"
volume="5677159.00"
latest_trading_day="2023-08-30"
previous_close="3.38"
change="-0.10"
change_percent="-2.9586%"
aroon_positive_momentum_days="23"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="23"
Volume_recent_avg="2770688"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.56"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="23"
Aroon_momentum_negative="77"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="658"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
